The impact of primary diseases is substantial, demanding fresh therapeutic modalities. Cellular therapies represent a especially exciting avenue, offering the possibility to restore damaged hepatic tissue and enhance clinical outcomes. Currently, research focuses on several methods, including the administration of induced pluripotent cellular entit